NSC |
Compound |
Enrichment |
Correlation |
NSC 59220 |
[[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt |
0.0287337488682932 |
-0.30735105 |
NSC 600684 |
Null |
0.0287337488682932 |
0.14730107 |
NSC 610459 |
Camptothecin Derivative |
0.0287337488682932 |
-0.19873147 |
NSC 623176 |
Null |
0.0287337488682932 |
-0.050633674 |
NSC 627748 |
Null |
0.0287337488682932 |
-0.025400143 |
NSC 633016 |
Null |
0.0287337488682932 |
-0.024557515 |
NSC 650792 |
1,4,7,10-Tetrathia-13-azacyclopentadecane, 13-[(4-methylphenyl)sulfonyl]- |
0.028864316650669 |
-0.033163939 |
NSC 676498 |
TP4EK-K6 |
0.028864316650669 |
-0.17715196 |
NSC 680721 |
5H-1,4,8,11-Benzotetrathiacyclotridecin- 13,14-dicarbonitrile, 2,3,6,7,9,10-hexahydro- |
0.028864316650669 |
-0.1235161 |
NSC 108165 |
CP 12252-1 |
0.0288643166506692 |
0.20769141 |